About this trial
Despite the deleterious impact of smoking upon cancer treatment outcomes, smoking prevalence remains alarmingly high among cancer patients. Thus, reducing smoking by cancer patients is a public health priority, but treatments to date have demonstrated limited efficacy. Mobile health (mHealth) interventions have the potential to improve treatment efficacy while also greatly extending reach. The goal of this infrastructure proposal is to build a resource to facilitate the creation of mHealth tools that address the tobacco treatment needs of cancer patients. This resource, which will be available to researchers throughout Florida, would fill a critical gap in mHealth capacity.
Eligibility criteria
Qualifiers
≥18 years of age.
≥100 lifetime cigarettes.
English-speaking.
Report smoking ≥ 1 cigarette in past 30 days.
Disqualifiers
Failure to electronically confirm participation within 14 days of randomization via electronic link sent to participant's smartphone.
Currently pregnant or breastfeeding.
Trial design
Treatments tested in this trial
- Quitline Treatment (QT)
- App-based Treatment (mHealth)
Treatment groups
Sponsors and collaborators
H. Lee Moffitt Cancer Center and Research Institute
Lead sponsor
Florida Biomedical Research Program - James & Esther King
Collaborator